tiprankstipranks
Trending News
More News >
Instil Bio, Inc. (TIL)
NASDAQ:TIL
US Market

Compare Instil Bio (TIL) vs. Competitors

Compare
380 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Instil Bio
$7.18
$50.12M
-0.65
-66.41%
0 Buy
2 Hold
0 Sell
Hold
Zentalis Pharmaceuticals
$1.41
$205.19M
-1.36
2.16%
4 Buy
2 Hold
0 Sell
Moderate Buy
Nkarta
$2.11
$149.87M
-1.52
-11.72%
4 Buy
1 Hold
0 Sell
Strong Buy
ALX Oncology Holdings
$1.24
$67.23M
-0.61
-32.97%
3 Buy
1 Hold
0 Sell
Strong Buy
Surrozen
$19.06
$163.37M
-0.87
48.79%
3 Buy
0 Hold
0 Sell
Strong Buy
TScan Therapeutics
$1.18
$66.96M
-1.05
-58.60%
5 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TIL
Instil Bio
7.39
-11.63
-61.15%
ZNTL
Zentalis Pharmaceuticals
2.84
0.28
10.94%
NKTX
Nkarta
2.11
-0.20
-8.66%
ALXO
ALX Oncology Holdings
1.24
-0.45
-26.63%
SRZN
Surrozen
19.06
7.74
68.37%
TCRX
TScan Therapeutics
1.18
-1.54
-56.62%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts